AzTrials
AzTrials

Phantom Limb PainMrMAPPNCT04529083

Mixed Reality Based System to Manage Phantom Pain Phantom Pain for Patients With Lower Limb Amputation

A study testing Mr. MAPP in people with Phantom Limb Pain, run by Dallas VA Medical Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary goals of this pilot research project are a) to design and develop the a mixed reality based system for managing phantom pain and b) to evaluate the feasibility and preliminary functional outcomes of this system in a sample of patients with lower limb amputation. Read more about this study

Who is it for?
Any age
Conditions the study is for
Phantom Limb Pain
What is being tested?
Mr. MAPP
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
11 participants
Where
1 siteUnited States
Study dates
21 May 2018to 31 Jul 2022
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Men and women, over the age of 18 with lower limb amputations (greater than 3 months post surgery) with phantom limb pain

Who cannot join

  • Patients with lower limb amputations with open wounds or active infection in residual or contralateral limbs.
  • Patients with history of seizures.
  • Patients with visual (self-reported) or cognitive impairment (assessed by the mini-mental state examination) that interferes with ability to interact with, participate in, and adhere to a computerized rehabilitation system.
  • Any patient with a cardiac event in the last 6 months.
  • Any patient with an active medical issue to minimize risk of exacerbating their condition.
  • Lives more than 60 miles away from the Dallas VA Medical Center
  • Any patient with the motion sickness induced by head mounted displays (HMDs) or immersive environment.
  • Any patient experiencing the motion sickness induced by HMDs during the therapy session can also opt out of the study.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • VA North Texas Health Care System

    Dallas, Texas, 75216

Other trials in United States

About this study

Official title: Feasibility and Functional Outcomes of a Novel Mixed Reality Based System to Manage Phantom Pain for Patients With Lower Limb Amputation.

The primary goals of this pilot research project are a) to design and develop the a mixed reality based system for managing phantom pain and b) to evaluate the feasibility and preliminary functional outcomes of this system in a sample of patients with lower limb amputation. Findings from this pilot study will serve as preliminary data to inform regarding a fully powered clinical trial to determine the effectiveness and practical implementation of these findings in real-world settings.

Aim1: Design and develop a feasible mixed reality based system to manage phantom pain in patients with lower limb amputation qualifying for on-going mirror therapy.

Read more

Hypothesis 1: The investigators hypothesize that the mixed reality based system to manage phantom pain will be feasible and well-received by a sample of patients with lower limb amputation needing mirror therapy.

Aim2: Evaluate functional outcomes in a sample of lower limb amputees (n=10), using this mixed reality based system to manage phantom pain.

Hypothesis 2: Using this system, the investigators hypothesize that patients who participate in the mixed reality based system will show improvements in functional mobility based on performance evaluations and patient reported outcome measures (PROs). The investigators also hypothesize that this mixed reality based system will help to alleviate the phantom pain based on McGill Pain questionnaire and visual analog scale (VAS).

Read the detailed description

The primary goals of this pilot research project are a) to design and develop the a mixed reality based system for managing phantom pain and b) to evaluate the feasibility and preliminary functional outcomes of this system in a sample of patients with lower limb amputation. Findings from this pilot study will serve as preliminary data to inform regarding a fully powered clinical trial to determine the effectiveness and practical implementation of these findings in real-world settings.

Aim1: Design and develop a feasible mixed reality based system to manage phantom pain in patients with lower limb amputation qualifying for on-going mirror therapy.

Hypothesis 1: The investigators hypothesize that the mixed reality based system to manage phantom pain will be feasible and well received by a sample of patients with lower limb amputation needing mirror therapy.

Aim2: Evaluate functional outcomes in a sample of lower limb amputees (n=10), using this mixed reality based system to manage phantom pain.

Hypothesis 2: Using this system, the investigators hypothesize that patients who participate in the mixed reality based system will show improvements in patient-reported outcome measures (PROs). The investigators also hypothesize that this mixed reality based system will help to alleviate the phantom pain based on Pain questionnaires and visual analog scale (VAS).

Patients 18 years of age and over with history of lower limb amputation and complaint of phantom limb pain. Phantom limb pain is a condition experienced commonly by patients with major limb amputations.

Men and women, over the age of 18 with lower limb amputations (greater than 3 months post surgery) with phantom limb pain.

-Exclusion criteria: ---

  • Patients with lower limb amputations with open wounds or active infection in residual or contralateral limbs
  • Patients with history of seizures.
  • Patients with visual (self-reported) or cognitive impairment (assessed by the mini-mental state examination) that interferes with ability to interact with, participate in, and adhere to a computerized rehabilitation system.
  • Any patient with a cardiac event in the last 6 months.
  • Any patient with an active medical issue to minimize risk of exacerbating their condition.
  • Lives more than 60 miles away from the Dallas VA Medical Center
  • Any patient with the motion sickness induced by head mounted displays (HMDs) or immersive environment.
  • Any patient experiencing the motion sickness induced by HMDs during the therapy session can also opt out of the study.

In this exploratory, pilot study, a convenience sample of 10 patients will be recruited. A sample of 10 subjects is adequate and consistent with other pilot behavioral intervention trials at the VA that have been completed and published.

This is a pilot study is intended to yield preliminary data that will inform a fully powered trial to determine effectiveness of the novel Mixed Reality based system to manage phantom pain.A HIPAA waiver will be obtained to screen patients with lower limb amputation in the outpatient PM\&R clinics. Eligible study candidates will be identified either during an initial visit as an outpatient during clinic visit with the physiatrist. or review of prior visit with physiatrist. The eligible, pre-screened subjects will undergo a basic evaluation (by rehabilitation physician ). After the evaluation, the patient will be asked to participate in the study or sent invitation letter. Once the eligible patient consents to enroll in the study with specific emphasis on safely performing the exercises independently at home. The research team will provide the laptop, camera and instruct the patient in its use at their home. The patient will then use the system and perform the personalized home exercises every day for a 1 month period (to evaluate sustainability of exercise behavior). At the end of this period, the system will be returned. At initial clinic visit, visit at week 1 and 1 month visit, the patient will fill out pain questionnaires, functional questionnaire without any identifiable PHI. The images of the patients performing the exercises will be stored in the encrypted laptop and analyzed at UTD. Also, that the videos at UTD will be destroyed after 5 years, but a copy will be kept at the Dallas VA.

A HIPAA waiver will be obtained to screen patients with lower limb amputation in the outpatient clinics. Eligible study candidates will be identified based on visit as an outpatient, following hospital discharge, the eligible, pre-screened subjects will undergo a basic evaluation (by rehabilitation physician). After the evaluation, the patient will be asked to participate in the study in person or by invitation letter. Once the eligible patient consents to enroll in the study with specific emphasis on safely performing the exercises independently at home. The research team will provide the laptop, camera and instruct the patient in its use at their home. The patient will then use the system and perform the personalized home exercises every day for a 1 month period (to evaluate sustainability of exercise behavior). At the end of this period, the system will be returned by the patient at the final study visit or can be retrieved at subject's home at subjects request if unable to bring to final visit by research assistant. Setting of the Study: The subject will be participating in a therapy session of 15 minutes per day for a duration of 4 weeks. Before starting a session, the subject will be provided with oral instructions about the overall system and the purpose of study. They will be asked to fill out a questionnaire asking the status of phantom pain, phantom limb movement, stress level etc. After completing the questionnaire, they will be allowed to move in virtual world to get acquainted. Each session consists of three sub-sections where the subject is asked to play three different virtual games. These virtual games are designed specifically for lower limb amputees. Each game is targeting certain types of muscle movement. We focused mainly on three types of movements: 1) knee flexion and extension, 2) ankle dorsiflexion and planar flexion, and 3) tandem coordinated bilateral lower extremity movement. Each game will be played only for 5 minutes. After completing each sub-session, the subject is asked to fill out similar questionnaire to record the effect.

System Overview: The system consists of one Microsoft Kinect camera, Oculus Rift and a computer system with sufficient processing power. Microsoft Kinect is used to scan the person and to create corresponding 3D model. As shown in Figure 3, the 3D model for the phantom limb is obtained by mirroring the 3D model of the intact limb. So, the subject will be able to perceive both the limb in the virtual world. The system provides a mixed reality based implementation of mirror therapy for managing phantom pain.

Major features of this system include:

Unconstrained movement: As patient will be performing exercise in virtual environment, the movement is not restricted by limited space as in case of traditional mirror box therapy where user can only move in the limits of box dimension, Realistic illusion of phantom limb: As the Mr.MAPP framework is using RGB-D camera to capture the movement of patients intact limb and mirror it to create the illusion of the phantom limb, the illusion obtained is very realistic instead of using pre-built 3D model of a limb (See Figure 4), Patient Encouragement: Use of an immersive gaming environment motivates and keeps the patient engaging while performing exercise. With the help of virtual reality, various engaging game can be developed that helps to remove monotonousness in therapy sessions.

Feedback with positive Reinforcement: As each game is designed to encourage a patient to perform certain type of exercise, the points earned in the game motivates the patient to perform better, Adherence and compliance monitoring: by recording and annotating the therapy sessions, the coaching software will monitor parameters such as number of repetitions, dates and times of exercises, as well as correctness of performing the exercises. This will serve as a real-time diary which is considered more reliable than self-report diaries that rely on patient recall of activity,Functional Outcome Measures: a) Visual Analog Scale for pain measurement (VAS) and b) McGill Pain questionnaire, c) Additional questions that composite of the Mobility, Activities of Daily Living/Instrumental Activities of Daily Living, and Social Participation.

At the end of the study, the patient will have the option to leave feedback and suggestions for future use of this system.

Descriptive methods will be used to characterize the sample population. Pre-post t-tests or equivalent will be used to compare outcomes at one week and 1 month. Given the pilot nature of this proposed study, inferential statistics (and reporting of statistical significance) will not be used. Feasibility outcomes will be descriptive, including calculating the percent of individuals enrolled in the study versus those eligible and the percent of individuals who remain in the study at month 1. Aims 1 and 2 will help establish intervention acceptability and feasibility. The images of the patients will be stored in the encrypted laptop and analyzed at UTD. Also, that the videos at UTD will be destroyed after 5 years, but a copy will be kept at the Dallas VA .

Using weekly telephone support and online ad-hoc support features of the proposed system, adverse event data will be obtained and further intervention will be initiated as needed for any safety issues that may arise during this pilot study.

Being tested
Mr. MAPP
Keywords
mixed reality, phantom limb pain
Medical subject headings
Phantom Limb

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mr. MAPPDevice

    Mixed reality device to provide virtual mirror therapy to patients with phantom pain

Study groups in NCT04529083
Study groupRoleWhat they receive
InterventionExperimentalMixed Reality System for virtual mirror therapy
Receives: Device: Mr. MAPP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Numerical Rating Scale

    Pain intensity; 0-10; higher is worse

    Measured: baseline, 1-month

  2. Change in McGill Pain Questionnaire

    Pain intensity and interference; multiple scales; higher is worse. Range 0-78

    Measured: baseline, 1-month

Secondary outcomes (1)
  1. Change in Patient Specific Functional Questionnaire

    Patient specific functional questionnaire; multiple scales; higher is better; Range 0 to 10 for each activity

    Measured: baseline, 1-month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Aug 2020
  2. Study start21 May 2018
  3. Primary completion31 Jul 2022
  4. Study completion31 Jul 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
Pilot study to evaluate feasibility
Masking
None (open label)
Enrolment
11 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04529083
Sponsor's protocol ID
18-016
Acronym
MrMAPP
Status last verified
Mar 2024
First submitted
24 Aug 2020
Last updated
3 Jul 2024
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Data may be shared upon approval from concerned authorities if needed

Publications

  • Annapureddy D, Annaswamy TM, Raval G, Chung YY, Prabhakaran B. A novel mixed reality system to manage phantom pain in-home: results of a pilot clinical trial. Front Pain Res (Lausanne). 2023 Jun 2;4:1183954. doi: 10.3389/fpain.2023.1183954. eCollection 2023.

    PubMed 37332478
  • Annaswamy TM, Bahirat K, Raval G, Chung YY, Pham T, Prabhakaran B. Clinical feasibility and preliminary outcomes of a novel mixed reality system to manage phantom pain: a pilot study. Pilot Feasibility Stud. 2022 Oct 22;8(1):232. doi: 10.1186/s40814-022-01187-w.

    PubMed 36273191

Questions about this trial

What is this clinical trial studying?

A study testing Mr. MAPP in people with Phantom Limb Pain, run by Dallas VA Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 3 Jul 2024). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Numerical Rating Scale (time frame: baseline, 1-month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04529083, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jul 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in